Tak Takvorian - Massachusetts Gen Hosp, Canc Ctr

基本信息

浏览量：61

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Philip C. Amrein,Eyal C. Attar,Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen,Kathleen M. Leahy,David C. Fisher,Ann S. LaCasce,Eric D. Jacobsen,Philippe Armand,Robert P. Hasserjian,Lillian Werner,Donna Neuberg,Jennifer R. Brown

openalex（2023）

引用0浏览0引用

Ibrutinib Maintenance after Frontline Treatment in Patients with Mantle Cell Lymphoma

Reem Karmali,Jeremy S. Abramson,Deborah M. Stephens,Jeffrey Barnes,Jane N. Winter,Shuo Ma,Juehua Gao,Jason Kaplan,Adam M. Petrich,Ephraim Hochberg,Tak Takvorian,Xinlei Mi,Valerie Nelson,Leo I. Gordon,Barbara Pro

BLOOD ADVANCES（2023）

引用2浏览0WOS引用

Brentuximab Vedotin Plus Doxorubicin and Dacarbazine in Nonbulky Limited-Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, Elizabeth Bengston,Robert Redd,Jeffrey A. Barnes,Tak Takvorian,Lubomir Sokol,Frederick Lansigan,Philippe Armand,Bijal Shah,Eric Jacobsen,Rosalba Martignetti,Elyce Turba,Sara Metzler,Victoria Patterson,Ann S. LaCasce,Celeste M. Bello

BLOOD ADVANCES（2023）

引用11浏览0WOS引用

Zanubrutinib, Obinutuzumab, and Venetoclax with Minimal Residual Disease-Driven Discontinuation in Previously Untreated Patients with Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma: a Multicentre, Single-Arm, Phase 2 Trial

Jacob D. Soumerai,Anthony R. Mato,Ahmet Dogan,Venkatraman E. Seshan,Erel Joffe,Kelsey Flaherty,Jason Carter,Ephraim Hochberg,Jeffrey A. Barnes,Audrey M. Hamilton,Jeremy S. Abramson,Connie L. Batlevi,Matthew J. Matasar,Ariela Noy,Colette N. Owens,M. Lia Palomba,Anita Kumar,Tak Takvorian,Ai Ni,Morgan Choma,Chaya Friedman,Puja Chadha, Elizabeth Simkins,Jade Ruiters,Sidney Sechio, Daneal Portman,Lauren Ramos, Natascha Nolet, Neena Mahajan,Rosalba Martignetti,Joanna Mi, Krista Scorsune, Julia Lynch,Brianne McGree,Stephanie Hughes,Clare Grieve,Lindsey E. Roeker,Meghan Thompson,P. Connor Johnson,Mikhail Roshal,Jane Huang,Juliana Biondo, Qun Wu,Allison Jacob,Omar Abdel-Wahab,Andrew D. Zelenetz

The Lancet Haematology（2021）

引用65浏览0WOS引用

Zanubrutinib, Obinutuzumab, and Venetoclax in Chronic Lymphocytic Leukemia: Early MRD Kinetics Define a High-Risk Patient Cohort with Delayed Bone Marrow Undetectable MRD and Earlier Post-Treatment MRD Recurrence

Jacob D. Soumerai,Anthony R. Mato,Ahmet Dogan,Venkatraman Seshan,Erel Joffe,Kelsey Flaherty,Jason Carter,Ephraim P. Hochberg,Jeffrey A. Barnes,Audrey Hamilton,Jeremy S. Abramson,Connie Lee Batlevi,Matthew J. Matasar,Ariela Noy,Colette Owens,M. Lia Palomba,Anita Kumar,Tak Takvorian,Ai Ni,Morgan Choma,Chaya Friedman,Puja Chadha, Elizabeth Simkins,Jade Ruiters,Sidney Sechio, Daneal Portman, Natascha Nolet, Neena Mahajan,Rosalba Martignetti,Joanna Mi, Krista J. Scorsune, Julia M. Lynch,Brianne McGree, Stephanie Y. Hughes,Clare Grieve,Lindsey E. Roeker,Meghan C. Thompson,P. Connor Johnson,Mikhail Roshal,Jane Huang,Juliana M. L. Biondo,Jenny Qun Wu,Allison P. Jacob,Omar Abdel-Wahab,Andrew D. Zelenetz

Blood（2021）

引用1浏览0引用

Safety and Efficacy of Ibrutinib Maintenance (I-M) Following Frontline Induction in Mantle Cell Lymphoma (MCL) with Sequential Assessment of Changes in NGS-MRD

Reem Karmali,Jeremy S. Abramson,Deborah M. Stephens,Jeffrey A. Barnes,Jason Kaplan,Jane N. Winter,Shuo Ma,Juehua Gao,Adam M. Petrich,Ephraim Hochberg,Tak Takvorian,Frank Kuhr,Lik Wee Lee,Valerie Nelson,Leo I. Gordon,Barbara Pro

Blood（2021）

引用1浏览0引用

Ibrutinib Maintenance Following Induction for Untreated Mantle Cell Lymphoma (MCL): Initial Safety Report

Reem Karmali,Jeremy S. Abramson,Deborah Marie Stephens,Jeffrey A. Barnes,Jason B. Kaplan,Jane N. Winter,Shuo Ma,Adam Matthew Petrich,Ephraim P. Hochberg,Tak Takvorian,Valerie Nelson,Leo I. Gordon,Barbara Pro

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用2浏览0引用

Panobinostat in Combination with Rituximab in Heavily Pretreated Diffuse Large B‐cell Lymphoma: Results of a Phase II Study

Jeffrey A. Barnes,Robert Redd,David C. Fisher,Ephraim P. Hochberg,Tak Takvorian,Donna Neuberg,Eric Jacobsen,Jeremy S. Abramson

Hematological Oncologyno. 4 (2018): 633-637

引用17浏览0WOS引用

Brentuximab Vedotin Plus Avd for Non-Bulky Limited Stage Hodgkin Lymphoma: A Phase Ii Trial

Jeremy S. Abramson,Jon E. Arnason,Ann S. LaCasce,Robert Redd,Jeffrey A. Barnes,Lubomir Sokol,Robin Joyce,David Avigan,Donna S. Neuberg,Tak Takvorian,Ephraim P. Hochberg,Celeste M. Bello

JOURNAL OF CLINICAL ONCOLOGY（2015）

引用20浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn